Advancements in chronic wound healing materials

Researchers are investigating new materials and formulations to improve the treatment of chronic wounds, particularly for patients with conditions such as diabetes.

At Flinders University’s Biomedical Nanoengineering Laboratory, scientists have identified vanillin as a potential candidate for wound-healing formulations. Due to its antioxidant, anti-inflammatory, and antibacterial properties, vanillin is being studied as a cost-effective and safe solution for ulcer treatment and targeted drug delivery. Lead researcher Dr. Krasimir Vasilev noted that the compound’s abundance and safety history make it a strong candidate for medical applications.

A literature study published in the ‘International Journal of Pharmaceutics’ suggests that vanillin’s amphiphilic molecular structure allows it to interact with cell membranes and polymer matrices. This enables it to be integrated into various drug delivery platforms, where it can act as both an active healing agent and a chemical crosslinker. For instance, it can form bonds with natural polymers like chitosan to create self-healing hydrogels. In preclinical contexts, vanillin has demonstrated the ability to fight bacterial infections, including multi-resistant E. coli, reduce oxidative stress, and stimulate skin repair cells like keratinocytes and fibroblasts to promote faster wound closure.

In parallel, researchers at Empa are developing smart wound therapies using materials that release active ingredients when exposed to visible light. By loading silica nanoparticles with specific agents, the team aims to create wound patches that allow for controlled drug delivery to improve treatment effectiveness for conditions like diabetic foot syndrome.